Interact to see
Advertisement
Advertisement
BIOPX vs RGACX
BIOPX vs RGACX Comparison
Open Charts BIOPX vs RGACX
Baron Opportunity Retail
Price$52.14
Change+$0.10 (+0.19%)
VolumeN/A
Net Assets1.71B
American Funds Growth Fund of Amer R3
Price$82.10
Change-$0.06 (-0.07%)
VolumeN/A
Net Assets329.22B
BIOPX vs RGACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
BIOPX vs. RGACX commentary
Aug 18, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIOPX is a StrongBuy and RGACX is a Buy.
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 329B vs. BIOPX (1.71B). RGACX pays higher dividends than BIOPX: RGACX (0.07) vs BIOPX (0.00). BIOPX was incepted earlier than RGACX: BIOPX (25 years) vs RGACX (23 years). BIOPX (1.31) is less costly to investors than RGACX (0.94). BIOPX is a more actively managed with annual turnover of: 33.00 vs. RGACX (25.00). RGACX has a lower initial minimum investment than BIOPX: RGACX (250) vs BIOPX (2000). BIOPX annual gain was more profitable for investors over the last year : 23.79 vs. RGACX (14.08). BIOPX return over 5 years is better than : 61.32 vs. RGACX (41.95).
| BIOPX | RGACX | BIOPX / RGACX | |
| Total Expense Ratio | 1.31 | 0.94 | 139% |
| Annual Report Gross Expense Ratio | 1.31 | 0.94 | 139% |
| Fund Existence | 25 years | 23 years | - |
| Gain YTD | 10.630 | 14.044 | 76% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2000 | 250 | 800% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.71B | 329B | 1% |
| Annual Yield % from dividends | 0.00 | 0.07 | - |
| Returns for 1 year | 23.79 | 14.08 | 169% |
| Returns for 3 years | 70.45 | 41.19 | 171% |
| Returns for 5 years | 61.32 | 41.95 | 146% |
| Returns for 10 years | 172.13 | 83.68 | 206% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement